Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Immunity, 2026
Skin inflammation and itch response are independently regulated by distinct nociceptor subsets

Voisin T., Gheziel N., El Samrout C. et al.

Olink Target 48 MouseDermatological DiseasesPathophysiologyMouse Tissue Lysate

Nature Medicine, 2026
Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypes

Li C., Richards S., Quinn G. et al.

Olink Explore 3072/384NephrologyCross-platform ValidationPlasma

Archives of Gerontology and Geriatrics, 2026
Plasma proteins mediate the protective association between physical activity and osteoporosis risk: A prospective study in the UK biobank

Liu B., Luo S., Geng Z. et al.

Olink Explore 3072/384OrthopedicsPathophysiologyPlasma

Blood Journal, 2026
CD28⁺ CD8⁺ Tem cells with a STAT1-dependent glucocorticoid receptor deficit contribute to steroid-refractory acute GVHD

Pan Z., Deng Y., Huang J. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Heart and Mind, 2026
Causal Effect of 91 Inflammatory Cytokines on Intrinsic Capacity Domains: A Two-Sample Mendelian Randomization Study

Hu M., Gong Z., Li X. et al.

Olink Target 96AgingPathophysiologyPlasma

Emerging Contaminants, 2026
Alternative plasticizers induced immunotoxicity in THP-1 macrophages via mitochondrial dysfunction-driven metabolic reprogramming

Zheng S., Zhao B., Lin X. et al.

Olink Target 96Environmental Health & ToxicologyPathophysiologyCell Culture Lysate

Frontiers in Cardiovascular Medicine, 2026
Combined diagnostic value of NT-proBNP, DLK-1, PSP-D and PCSK-9 in heart failure with preserved ejection fraction: a prospective biomarker study

Xiaobin L., Yu Q., Jingjie F. et al.

Olink Target 96CVDPatient StratificationSerum

Cancer Discovery, 2026
GPNMB Drives Brain Metastasis by Sculpting a Pathological Endothelial-Immune Interactome

Liu X., Tan J., Wu C. et al.

Olink Target 96OncologyPathophysiologyPlasma

Journal of Exposure Science & Environmental Epidemiology, 2026
Pilot proteomics study for identifying a pollution exposure signature in firefighters

Ding V., Lu D., Ji Y. et al.

Olink Explore 3072/384Environmental Health & ToxicologyPatient StratificationPlasma

Communications Medicine, 2026
Divergent inflammatory and neurology-related protein levels in long COVID following primary and breakthrough SARS-CoV-2 infections

Bansal A., Olechnowicz S., Kiernan-Walker N. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

eBioMedicine, 2026
Blood-based biomarker discovery for early pregnancy loss using integrative multi-omics strategies

Shi Y., Yang Y., Guo X. et al.

Olink Target 96ObstetricsPathophysiologyPatient StratificationSerum

Nature Medicine, 2026
Plasma proteomic signature of the human menstrual cycle

Riishede I., Rode L., Lundegaard P. et al.

Olink Explore 3072/384GynecologyPathophysiologyPatient StratificationPlasma

Cancer Pathogenesis and Therapy, 2026
Genetically predicted inflammatory mediators link mitochondrial function to breast cancer risk: A Mendelian randomization study

Ran L., Feng J., Chen J. et al.

Olink Target 96OncologyPathophysiologyPlasma

Archives of Gerontology and Geriatrics, 2026
Hepatic dysfunction and long-term risk of neurodegenerative diseases: A UK Biobank-based analysis

Su W., Duan Q., He S. et al.

Olink Explore 3072/384NeurologyHepatologyPathophysiologyPlasma

Diabetic Medicine, 2026
A multi‐omics risk score enables early and personalized screening for type 2 diabetes: A population‐based cohort study

Bu F., Fang C., Zheng X. et al.

Olink Explore 3072/384Metabolic DiseasesPatient StratificationPlasma

eBioMedicine, 2026
Distinct metabolic signatures of Alzheimer's and Parkinson's disease revealed through genetic overlap

Stinson S., Shadrin A., Rahman Z. et al.

Olink Explore 3072/384Metabolic DiseasesNeurologyPathophysiologyPlasma

Lipids in Health and Disease, 2026
Associations of plasma level of soluble LDL receptor with cardiovascular events and mortality in a large prospective cohort study

Kim S., Jun H., Jo G. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

Journal for ImmunoTherapy of Cancer, 2026
Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Sato Y., Kodama T., Maesaka K. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

Journal of the American Society of Nephrology, 2026
RARRES1 Promotes Tubular Fibrosis via the KHDRBS1/Src/p-STAT3 Axis

Ye L., Jiang Z., Wu Y. et al.

Olink Explore 3072/384NephrologyPathophysiologyPlasma

ESC Heart Failure, 2026
Plasma protein profiles in different heart failure phenotypes

Lind L., Delgado-Velandia M.

Olink Explore 3072/384CVDPatient StratificationPlasma

3984 publications